In vitro activities of amoxicillin-clavulanate, doxycycline, ceftazidime, imipenem, and trimethoprim-sulfamethoxazole against biofilm of Brazilian strains of Burkholderia pseudomallei

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 11, 2013, Pages 5771-5773

  De Jesus Pinheiro Gomes Bandeira, Tereza ^a,c   Moreira, Camila Alencar ^a   Brilhante, Raimunda Sâmia Nogueira ^a   De Souza Collares Maia Castelo Branco, Débora ^a   De Araújo Neto, Manoel Paiva ^a,b   De Aguiar Cordeiro, Rossana ^a   De Jesus Santos Rodrigues, Terezinha ^a   Rocha, Marcos Fábio Gadelha ^a,b   Sidrim, José Júlio Costa ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b STATE UNIVERSITY OF CEARÁ   (Brazil)

^c LabPasteur DASA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM; CEFTAZIDIME; COTRIMOXAZOLE; CRYSTAL VIOLET; DOXYCYCLINE; IMIPENEM; PHOSPHATE BUFFERED SALINE; RESAZURIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL; BACTERICIDAL ACTIVITY; BIOFILM; BRAZIL; BROTH DILUTION; BURKHOLDERIA PSEUDOMALLEI; DRUG DIFFUSION; ESCHERICHIA COLI; GROWTH RATE; IN VITRO STUDY; MELIOIDOSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; BIOFILMS; BRAZIL; BURKHOLDERIA PSEUDOMALLEI; CEFTAZIDIME; DOXYCYCLINE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; IMIPENEM; MICROBIAL SENSITIVITY TESTS; PLANKTON; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 84885917141     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00721-13     Document Type: Article

References (20)

1. Limmathurotsakul D, Peacock SJ. 2011. Melioidosis: A clinical overview. Br. Med. Bull. 99:125-139.
2. Cheng AC, Currie BJ. 2005. Melioidosis: Epidemiology, pathophysiology, and management. Clin. Microbiol. Rev. 18:383-416.
3. White NJ. 2003. Melioidosis. Lancet 361:1715-1722.
4. Brilhante RSN, Valente LGA, Rocha MFG, Bandeira TJPG, Cordeiro RA, Lima RAC, Leite JJG, Ribeiro JF, Pereira JF, Castelo-Branco DSCM, Monteiro AG, Sidrim JJC. 2012. Sesquiterpene farnesol contributes to increased susceptibility to -lactams in strains of Burkholderia pseudomallei. Antimicrob. Agents Chemother. 56:2198-2200.
5. Sawasdidoln C, Taweechaisupapong S, Sermswan RW, Tattawasart U, Tungpradabkul S, Wongratanacheewin S. 2010. Growing Burkholderia pseudomallei in biofilm stimulating conditions significantly induces antimicrobial resistance. PLoS One 5(2):e9196. doi:10.1371/journal.pone.0009196.
6. Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. 2010. Antibiotic resistance of bacterial biofilms. Int. J. Antimicrob. Agents 35:322-332.
7. Pibalpakdee P, Wongratanacheewin S, Taweechaisupapong S, Niumsup PR. 2012. Diffusion and activity of antibiotics against Burkholderia pseudomallei biofilms. Int. J. Antimicrob. Agents 39:356-359.
8. Stepanovic S, Vukovic D, Dakic I, Savic B, Svabic-Vlahovic M. 2000. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J. Microbiol. Methods 49:175-179.
9. Moreira CA, Oliveira LC, Mendes MS, Santiago TM, Barros EB, Carvalho CBM. 2012. Biofilm production by clinical Staphylococci strains from canine otitis. Braz. J. Microbiol. 43:371-374.
10. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved standard. CLSI document M07-A8. CLSI, Wayne, PA.
11. Roveta S, Schito AM, Marchese A, Schito GC. 2007. Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis. Int. J. Antimicrob. Agents 30: 415-421.
12. Peeters E, Nelis HJ, Coenye T. 2008. Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J. Microbiol. Methods 72:157-165.
13. Pettit RK, Weber CA, Kean MJ, Hoffman H, Pettit GR, Tan R, Franks KS, Horton ML. 2005. Microplate alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing. Antimicrob. Agents Chemother. 49:2612-2617.
14. Toté K, Vanden Berghe D, Maes L, Cos P. 2008. A new colorimetric microtitre model for the detection of Staphylococcus aureus biofilms. Lett. Appl. Microbiol. 46:249-254.
15. Sarker SD, Nahar L, Kumrasamy Y. 2007. Microtitre plate-based antibacterial assay incorporating resazurin as an indicator of cell growth, and its application in the in vitro antibacterial screening of phytochemicals. Methods 42:321-324.
16. Sandberg ME, Schellmann D, Brunhofer G, Erker T, Busygin I, Leino R, Vuorela PM, Fallarero A. 2009. Pros and cons of using resazurin staining for quantification of viable Staphylococcus aureus biofilm in a screening assay. J. Microbiol. Methods 78:104-106.
17. Clinical and Laboratory Standards Institute. 2010. Methods for antimicrobial dilution and disk susceptibility tests of infrequently isolated or fastidious bacteria. Approved guideline. CLSI document M45-A2, 2nd ed. Clinical and Laboratory Standards Institute, Wayne, PA.
18. Kwan BW, Valenta JA, Benedik MJ, Wood TK. 2013. Arrested protein synthesis increases persister-like cell formation. Antimicrob. Agents Chemother. 57:1468-1473.
19. Rholl DA, Papp-Wallace KM, Tomaras AP, Vasil ML, Bonomo RA, Schweizer HP. 2011. Molecular investigations of PenA-mediated -lactam resistance in Burkholderia pseudomallei. Front. Microbiol. 2:139. doi: 10.3389/fmicb.2011. 00139.
20. Schweizer HP. 2012. Mechanisms of antibiotic resistance in Burkholderia pseudomallei: Implications for treatment of melioidosis. Future Microbiol. 7:1389-1399.